|
Main | | | | | | | | | | | | | | | | | | | | | | | | | |
| Brand Name | Risperdal Consta | | | | | | | | | | | | | | | | | | | | | | | |
| Generic Name | risperidone | | | | | | | | | | | | | | | | | | | | | | | |
| Administration | Intramuscular | | | | | | | | | | | | | | | | | | | | | | | |
| Mechanism | Atypical antipsychotic. Dopamine and serotonin subreceptor antagonist. | | | | | | | | | | | | | | | | | | | | | | | |
| Economics | Royalty to Alkermes (ALKS). | | | | | | | | | | | | | | | | | | | | | | | |
| Approved | 10/29/2003 US. | | | | | | | | | | | | | | | | | | | | | | | |
| IP | US 11/2013: method of use for treatment of schizophrenia. Maximum 6/30/2019. | | | | | | | | | | | | | | | | | | | | | | | |
| | 6110503 expires in 2017 and is an ALKS Medisorb patent. | | | | | | | | | | | | | | | | | | | | | | | |
| | 6596316 expires in 2019 and is an ALKS Medisorb patent. | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | 1Q03 | 2Q03 | 3Q03 | 4Q03 | 1Q04 | 2Q04 | 3Q04 | 4Q04 | 1Q05 | 2Q05 | 3Q05 | 4Q05 | 1Q06 | 2Q06 | 3Q06 | 4Q06 | 1Q07 | 2Q07 | 3Q07 | 4Q07 | 1Q08 | 2Q08 | 3Q08 | 4Q08 |
| US | 5 | 10 | 16 | 30 | 41 | 55 | 60 | 74 | 104 | 114 | 134 | | | | | 102 | 101 | 102 | 111 | 108 | 101 | 134 | 134 | 134 |
| ROW | 46 | 57.4 | 70 | 76.4 | 78 | 89 | 101 | 104 | 106 | 112 | 124 | | | | | 124 | 160 | 176 | 183 | 187 | 208 | 124 | 124 | 124 |
| WW | 51 | 67.4 | 86 | 106.4 | 119 | 144 | 161 | 178 | 210 | 226 | 258 | | | | | 226 | 261 | 278 | 294 | 295 | 309 | 258 | 258 | 258 |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| US | | | | | | | | | | | | | | | | | | | | 0.05882352941176472 | 0 | | | |
| ROW | | | | | | | | | | | | | | | | | | | | 0.5080645161290323 | 0.30000000000000004 | | | |
| Y/Y | | | | | | | | | | | | | | | | | | | | 0.30530973451327426 | 0.1839080459770115 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2003 | 2004 | | | | | | | | | | | | | | | | | | | | | | |
| US | 61 | 230 | | | | | | | | | | | | | | | | | | | | | | |
| ROW | 249.8 | 372 | | | | | | | | | | | | | | | | | | | | | | |
| WW | 310.8 | 602 | | | | | | | | | | | | | | | | | | | | | | |